...
首页> 外文期刊>Journal of Hainan Medical University >Influence of folic acid and vitamin B12 combined therapy on plasma Hcy, inflammatory factor levels and blood vessels endothelial function in patients with vascular dementia and type H hypertension
【24h】

Influence of folic acid and vitamin B12 combined therapy on plasma Hcy, inflammatory factor levels and blood vessels endothelial function in patients with vascular dementia and type H hypertension

机译:叶酸和维生素B12联合治疗对血管性痴呆和H型高血压患者血浆Hcy,炎性因子水平和血管内皮功能的影响

获取原文
           

摘要

Objective: To investigate influence of folic acid and vitamin B12 combined therapy on plasmahomocysteine (Hcy) level, blood vessels endothelial function and inflammatory factors inpatients with vascular dementia and type H hypertension. Methods: 100 cases of patients withvascular dementia and type H hypertension accorded with the inclusion criteria were selectedas research objects. They were randomly divided as the control group and the therapeuticgroup, 50 cases each. For control group, Enalapril tablets were administered by mouth fortreatment. For therapeutic group, folic acid and vitamin B12 treatment were provided on thebasis of treatment for control group. Treatments were continued for 12 weeks. Plasma Hcylevels, inflammatory factors [(interleukin-6 (IL-6), interleukin-8 (IL-8) and hypersensitive Creaction protein (hs-CRP)], blood vessels endothelial function indexes variation in patientsbefore and after treatment were observed and detected. Results: Plasma Hcy, IL-6, IL-8and hs-CRP levels in two groups of patients after treatment were significantly decreasedcomparing with the same group before treatment, and the above index levels in therapeuticgroup after treatment were significantly lower than control group (P0.05); After treatment, diastolic pressure and systolicpressure in the two groups of patients were significantly improved comparing with beforetreatment (P0.05). MMSE score in therapeutic groupafter treatment was significantly higher than before treatment, and significantly higher thanin control group (P0.05). Conclusions: Combined therapy of folic acid and vitamin B12 fortreating vascular dementia with type H hypertension could effectively decrease plasma Hcyand inflammatory factor levels, and improve blood vessels endothelial function and dementiadegree on patients. It has certain clinical value which deserves to be promoted.
机译:目的:探讨叶酸和维生素B12联合治疗对血管性痴呆和H型高血压患者血浆同型半胱氨酸(Hcy)水平,血管内皮功能和炎性因子的影响。方法:选择符合纳入标准的100例血管性痴呆合并H型高血压患者作为研究对象。将他们随机分为对照组和治疗组,各50例。对于对照组,依那普利片经口给药。对于治疗组,在对照组治疗的基础上提供叶酸和维生素B12治疗。治疗持续12周。观察和检测患者治疗前后血浆中的半胱氨酸水平,炎症因子[(白介素-6(IL-6),白介素8(IL-8)和过敏性Creaction蛋白(hs-CRP)],血管内皮功能指标的变化。结果:治疗后两组患者血浆Hcy,IL-6,IL-8和hs-CRP水平较治疗前相同组明显降低,治疗后上述指标水平显着低于对照组( P0.05);治疗后两组患者的舒张压和收缩压均较治疗前有明显改善(P0.05)。治疗后治疗组MMSE评分明显高于治疗前,且明显高于对照组(P0.05)。 P <0.05)。结论:叶酸和维生素B12联合治疗血管性痴呆合并H型高血压可有效​​降低血浆Hcyand infl促发因子水平,并改善患者的血管内皮功能和痴呆程度。具有一定的临床价值,值得推广。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号